What is Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (002603.SZ) StockRank?

MoatMap's StockRank for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) is 96/100, with a Strong Buy signal. This is a composite score combining Quality (79), Value (58), and Momentum (54) factor ranks across MoatMap's 19,000+ stock universe.

Does Shijiazhuang Yiling Pharmaceutical Co., Ltd. have an economic moat?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shijiazhuang Yiling Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shijiazhuang Yiling Pharmaceutical Co., Ltd. in?

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002603.SZ

STRONG BUYREMOVE

Shijiazhuang Yiling Pharmaceutical Co., Ltd. · Healthcare · China · $4.0B · Avg Vol: $35M/d

StockRank

P/E (TTM)

19.4x

ROE

12.5%

D/E

0.0x

Dividend %

5.1%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shijiazhuang Yiling Pharmaceutical is focused on Traditional Chinese Medicine. It lacks a global reinvestment runway, has low pricing power outside of China, and does not align with our CDMO or advanced healthcare themes.

COMPANY DESCRIPTION

Shijiazhuang Yiling Pharmaceutical is a leading Chinese pharmaceutical company specializing in patented Traditional Chinese Medicines (TCM). The company's flagship respiratory product, Lianhua Qingwen, holds a dominant market share in China's anti-viral and cold medicine segments. Its competitive moat is built on proprietary academic research and a robust pipeline of cardiovascular and oncology TCMs.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	1.9B	1.5B	963M	1.2B	-14.5%
EPS	0.21	0.12	-0.06	0.11	-18.3%
Shares	1.7B	1.7B	1.7B	1.7B	0.0%
Debt	129M	210M	4M	4M	-69.1%
Equity	1.6B	1.7B	1.5B	1.6B	0.2%
Op CF	515M	23M	90M	263M	-20.1%
Inv CF	-295M	-133M	238M	-148M	—
Fin CF	-94M	-33M	-333M	-76M	—

PRICE (1M)-6.5%

SMA 50SMA 200

$2.35

RSI (14)

47.2

52W High

$3.19

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

13.9%82.8

ROE

12.5%77.8

GP/Assets

37.8%76.7

Op. Margin

20.2%82.7

FCF/Assets

9.8%86.7

Piotroski

—83.5

Int. Cover

50.0x91.4

D/E Ratio

0.00x95.8

Current Ratio

2.50x46.0

Value

P/E (TTM)

19.4x58.5

EV/EBITDA

10.4x41.0

P/FCF

137.1x58.3

P/B

2.3x49.4

P/S

3.4x53.5

Div Yield

5.1%91.2

Momentum

52W High %

74%62.8

RS 6M

-23%50.2

SMA 50/200

0.96x51.8

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+33%43.8

Q Growth

25%66.5

FUNDAMENTALS

Market Cap

$4.0B

P/E (Forward)

14.6x

Gross Margin

65.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002603.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002603.SZ	Shijiazhuang Yiling Pharmaceutical Co., Ltd.(you)	$4.0B	96	STRONG BUY
000513.SZ	Livzon Pharmaceutical Group Inc.	$4.0B	94	STRONG BUY
600566.SS	Hubei Jumpcan Pharmaceutical Co., Ltd.	$3.8B	99	STRONG BUY
T14.SI	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	$3.2B	96	STRONG BUY
000423.SZ	Dong-E-E-Jiao Co., Ltd.	$4.8B	99	STRONG BUY
2096.HK	Simcere Pharmaceutical Group Limited	$3.3B	91	STRONG BUY
600380.SS	Joincare Pharmaceutical Group Industry Co.,Ltd.	$2.8B	94	STRONG BUY
600750.SS	China Resources Jiangzhong Pharmaceutical Co.,Ltd	$2.4B	95	STRONG BUY
000739.SZ	Apeloa Pharmaceutical Co.,Ltd	$2.8B	91	STRONG BUY
600535.SS	Tasly Pharmaceutical Group Co., Ltd	$3.1B	86	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) — Stock Score Summary

Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) has a MoatMap StockRank of 96/100 based on Quality (79/100), Value (58/100), and Momentum (54/100) factor scores. The current signal is STRONG BUY. Shijiazhuang Yiling Pharmaceutical is focused on Traditional Chinese Medicine. It lacks a global reinvestment runway, has low pricing power outside of China, and does not align with our CDMO or advanced healthcare themes.

Key Financial Metrics

Price	$2.35
Market Cap	$4.0B
P/E (TTM)	19.37
P/E (Forward)	14.57
Price/Book	2.33
Return on Equity	12.5%
Return on Invested Capital	13.9%
Debt/Equity	0.21
Gross Margin	65.1%
Operating Margin	20.2%
Revenue Growth	3.5%
Dividend Yield	5.1%
Free Cash Flow	$29M

Shijiazhuang Yiling Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shijiazhuang Yiling Pharmaceutical Co., Ltd.’s (002603.SZ) StockRank?: MoatMap’s StockRank for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) is 96/100, with a Strong Buy signal. It is a composite of Quality (79), Value (58), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shijiazhuang Yiling Pharmaceutical Co., Ltd. have an economic moat?: Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) has a Quality factor score of 79/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shijiazhuang Yiling Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) is Strong Buy, based on a StockRank of 96/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shijiazhuang Yiling Pharmaceutical Co., Ltd. in?: Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).